Cambridge Innovation Capital
01 · Thesis & focus
Cambridge-based fund managing over £500M, one of the most active Series A deeptech and life sciences investors in the Cambridge ecosystem (Pragmatic, Riverlane, Gyroscope); launched a £100M Opportunity Fund in 2025 backed by Aviva and British Patient Capital. A major established UK deeptech Series A lead.
02 · Recent publicly announced deals
Microbiotica develops defined live bacterial therapeutics for immuno-oncology and inflammatory bowel disease, using a clinic-led discovery platform to identify bacteria associated with patient outcomes and select relevant patient populations. Its methods include gut bacterial culturing, microbiome analysis, reference genome databases, bioinformatics, and microbiome–host biology research.
All-optical switches connecting GPUs across racks in AI data centers
Founders: Johannes F., Vaysh K., Wolfram P., Harish B.CMR Surgical develops a modular, portable robotic system for minimally invasive surgery, designed to fit into existing operating rooms and support familiar laparoscopic port placement and workflows. Its offering also includes a digital ecosystem that provides data and insights related to surgical care and operational efficiency.
03 · Similar firms
Hummingbird Ventures£500k – £10M · Also Seed · DeepTech
Oxford Innovation EIS Growth Fund£150k – £400k · Also Seed · DeepTech
Ananda Impact Ventures£5M – £15M · Also Seed · DeepTech NG Northern Gritstone
(undisclosed) · Also Seed · DeepTech
Elaia Partners£300k – £8M · Also Seed · DeepTech LC Lux Capital
£1M – £20M · Also Seed · DeepTech
What looks wrong? We review every submission.
Prefer email? kudei@concept.vc
We re-check public sources and update stages, deals and fund news. Each card can be refreshed once a week.
